Total Funding
74
21
Total FundingVenture - Series Unknown raised
Growth Score
-3 pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
506580
Neurotec Pharma is focused on developing new treatments for acute and chronic central nervous system (CNS) diseases.
Marco Pugliese: Founder and Chief Executive Officer
Manuel J Rodríguez: Founder and Scientific Consultant
About the Company
Neurotec Pharma SL is a spin-off of the University of Barcelona (UB) founded in 2006 and based in the Parc CientÃfic de Barcelona (PCB).
Neurotec centers its activity on developing new treatments for acute and chronic Central Nervous System (CNS) diseases. The proposed innovations are based in the possibility of controlling the activity of the
microglia cells that are implicated in a wide group of diseases related to inflammation or acute cerebral damage.
